Your browser doesn't support javascript.
loading
Translation Termination Factor GSPT1 Is a Phenotypically Relevant Off-Target of Heterobifunctional Phthalimide Degraders.
Ishoey, Mette; Chorn, Someth; Singh, Natesh; Jaeger, Martin G; Brand, Matthias; Paulk, Joshiawa; Bauer, Sophie; Erb, Michael A; Parapatics, Katja; Müller, André C; Bennett, Keiryn L; Ecker, Gerhard F; Bradner, James E; Winter, Georg E.
Afiliação
  • Ishoey M; Department of Medical Oncology , Dana-Farber Cancer Institute , Boston , Massachusetts 02115 , United States.
  • Chorn S; CeMM Research Center for Molecular Medicine of the Austrian Academy of Science , Lazarettgasse 14, AKH Bt. 25.3 , 1090 Vienna , Austria.
  • Singh N; University of Vienna , Department of Pharmaceutical Chemistry , Althanstrasse 14 , 1090 Vienna , Austria.
  • Jaeger MG; CeMM Research Center for Molecular Medicine of the Austrian Academy of Science , Lazarettgasse 14, AKH Bt. 25.3 , 1090 Vienna , Austria.
  • Brand M; CeMM Research Center for Molecular Medicine of the Austrian Academy of Science , Lazarettgasse 14, AKH Bt. 25.3 , 1090 Vienna , Austria.
  • Paulk J; Department of Medical Oncology , Dana-Farber Cancer Institute , Boston , Massachusetts 02115 , United States.
  • Bauer S; Novartis Institutes for Biomedical Research , Cambridge , Massachusetts 02139 , United States.
  • Erb MA; CeMM Research Center for Molecular Medicine of the Austrian Academy of Science , Lazarettgasse 14, AKH Bt. 25.3 , 1090 Vienna , Austria.
  • Parapatics K; Department of Medical Oncology , Dana-Farber Cancer Institute , Boston , Massachusetts 02115 , United States.
  • Müller AC; CeMM Research Center for Molecular Medicine of the Austrian Academy of Science , Lazarettgasse 14, AKH Bt. 25.3 , 1090 Vienna , Austria.
  • Bennett KL; CeMM Research Center for Molecular Medicine of the Austrian Academy of Science , Lazarettgasse 14, AKH Bt. 25.3 , 1090 Vienna , Austria.
  • Ecker GF; CeMM Research Center for Molecular Medicine of the Austrian Academy of Science , Lazarettgasse 14, AKH Bt. 25.3 , 1090 Vienna , Austria.
  • Bradner JE; University of Vienna , Department of Pharmaceutical Chemistry , Althanstrasse 14 , 1090 Vienna , Austria.
  • Winter GE; Department of Medical Oncology , Dana-Farber Cancer Institute , Boston , Massachusetts 02115 , United States.
ACS Chem Biol ; 13(3): 553-560, 2018 03 16.
Article em En | MEDLINE | ID: mdl-29356495
ABSTRACT
Protein degradation is an emerging therapeutic strategy with a unique molecular pharmacology that enables the disruption of all functions associated with a target. This is particularly relevant for proteins depending on molecular scaffolding, such as transcription factors or receptor tyrosine kinases (RTKs). To address tractability of multiple RTKs for chemical degradation by the E3 ligase CUL4-RBX1-DDB1-CRBN (CRL4CRBN), we synthesized a series of phthalimide degraders based on the promiscuous kinase inhibitors sunitinib and PHA665752. While both series failed to induce degradation of their consensus targets, individual molecules displayed pronounced efficacy in leukemia cell lines. Orthogonal target identification supported by molecular docking led us to identify the translation termination factor G1 to S phase transition 1 (GSPT1) as a converging off-target, resulting from inadvertent E3 ligase modulation. This research highlights the importance of monitoring degradation events that are independent of the respective targeting ligand as a unique feature of small-molecule degraders.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terminação Traducional da Cadeia Peptídica / Fatores de Terminação de Peptídeos / Proteólise Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terminação Traducional da Cadeia Peptídica / Fatores de Terminação de Peptídeos / Proteólise Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article